[1] Ma Q, Li R, Wang L, et al.Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: An analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12): e897-e906. [2] Wang J, Xiao C, Cheng Z, et al.Analysis and prediction of disease burden of stroke and its subtypes in China from 1990 to 2040[J]. Chin Med J (Engl), 2025, 138(19): 2452-2463. [3] 翟屹, 杨帆, 李天琪, 等. 中国卒中疾病负担与经济负担的整合分析[J]. 中国卒中杂志, 2025, 20(5): 566-580. [4] Richter KR, King P, Masters M, et al.Endothelial cell genetics in carotid artery atherosclerosis and intracranial atherosclerosis: A systematic review[J]. Stroke Vasc Interv Neurol, 2025, 5(6): e001813. [5] 陈盼, 张鑫磊, 王兰琴, 等. 经颅多普勒超声和颈动脉超声在椎基底动脉重度狭窄评估中的应用[J]. 江苏医药, 2025, 51(8): 762-765, 865. [6] 桑慧. 中国北方城乡脑卒中高危人群颈动脉粥样硬化特点及危险因素比较分析[D]. 太原: 山西医科大学, 2018. [7] 中华人民共和国国家卫生健康委员会. 脑血管病防治指南(2024年版)[J]. 磁共振成像, 2025, 16(1): 1-8. [8] 中国营养学会, 国家卫生健康委员会. 中国居民膳食指南(2022)[M]. 北京: 人民卫生出版社, 2022: 56. [9] 国家卫生计生委脑卒中防治工程委员会. 中国脑卒中血管超声检查指导规范[J]. 中华医学超声杂志, 2015, 12(8): 599-610. [10] 中国医师协会超声医师分会. 超声评价颈动脉易损斑块中国专家共识(2023版)[J]. 中华超声影像学杂志, 2023, 32(8): 645-655. [11] Saba L.Progress in the identification of unstable carotid artery plaque[J]. Curr Opin Neurol, 2026, 39(1): 1-6. [12] Chang X, Zhu H, Guo Z, et al.Expert consensus on the diagnosis and management of carotid atherosclerotic plaque: Pathophysiology, clinical management, and preventive approaches[J]. Int J Med Sci, 2025, 22(11): 2738-2756. [13] Van der laan KWF, Neutel CHG, Pencheva MG, et al. Vascular aging impairs active modulation of murine aortic stiffness by smooth muscle cells[J]. Am J Physiol Cell Physiol, 2025, 329(5): C1398-C1410. [14] Tattersall MC, Hansen SL, McClelland RL, et al. Importance of age and sex in carotid artery plaque detection and cardiovascular disease risk[J]. JAMA Cardiol, 2025, 10(5): 487-491. [15] Makena P, Haswell LE, McEwan M, et al. An adverse outcome pathway for cigarette smoke-mediated oxidative stress in plaque formation[J]. Front Toxicol, 2025, 7: 1554747. [16] Kim W.New insights on mechanisms of nicotine in neointimal hyperplasia[J]. Korean Circ J, 2025, 55(1): 65-66. [17] Maccioni R, Tambaro S, Doro L, et al.Timeless and stainless alcohol: Concentric waves from its oxidative metabolism and related oxidative stress[J]. Antioxidants (Basel), 2026, 15(2): 216. [18] Xu J, Xu S, Luo J, et al.Epigallocatechin-3-gallate alleviates ethanol-induced endothelia cells injury partly through alteration of NF-κB translocation and activation of the Nrf2 signaling pathway[J]. Biol Pharm Bull, 2024, 47(7): 1248-1254. [19] Robinson AT, Banks NF, Jenkins NDM.Exercise as vascular medicine: Can exercise combat negative health behaviors from causing endothelial dysfunction[J]. Exerc Sport Mov, 2025, 3(4): e00054. [20] Surma S, Okopień B, Murphy AJ, et al.High salt intake and atherosclerosis progression-not only via blood pressure: A narrative review[J]. Nutrients, 2025, 17(21): 3464. [21] Kazi RNA.Silent effects of high salt: Risks beyond hypertension and body's adaptation to high salt[J]. Biomedicines, 2025, 13(3): 746. [22] Del RÍO-SOLÁ ML, Fernández SP, Gonzalo-Benito H, et al. Redox imbalance and metabolic stress in carotid atherosclerosis: Associations with symptomatology and plaque calcification[J]. Nutr Metab Cardiovasc Dis, 2026, 36(3): 104423. [23] Lodi G, Sergi D, Dipinto A, et al.Hyperglycemia-induced endothelial dysfunction: From classical pathogenetic mechanisms to emerging insights into ACE2 protective action[J]. Int J Mol Sci, 2026, 27(6): 2660. [24] Liu J, Li K, Yi Z, et al.Oxidative-inflammatory crosstalk and multi-target natural agents: Decoding diabetic vascular complications[J]. Curr Issues Mol Biol, 2025, 47(8): 614. [25] Bolanle IO, de Liedekerke Beaufort G. Transcellular permeability of arterial endothelium to plasma LDL, an underexplored target in treating atherosclerosis: Novel insights and potential treatment strategies[J]. Vascul Pharmacol, 2025, 161: 107549. [26] Ugovšek S, Jeras J, Šebeštjen M, et al.Influence of LDL cholesterol and Lp(a) on monocytes and macrophages in atherosclerosis[J]. Biochem Med (Zagreb), 2025, 35(3): 030503. [27] Li M, Cui M, Li G, et al.The pathophysiological associations between obesity, NAFLD, and atherosclerotic cardiovascular diseases[J]. Horm Metab Res, 2024, 56(10): 683-696. [28] Tian W, Ju J, Guan B, et al.Role of hyperhomocysteinemia in atherosclerosis: From bench to bedside[J]. Ann Med, 2025, 57(1): 2457527. |